EVALUATING THE EFFECTIVENESS OF A NOVEL MULTIMODAL TREATMENT FOR AVASCULAR NECROSIS OF THE HEAD OF FEMUR OF POST COVID ETIOLOGY: A RETROSPECTIVE COHORT STUDY
Keywords:
Hydrotherapy, COVID 19, Femoral head necrosis, Risedronate, total hip replacementAbstract
Any vascular pathology causing interruption of blood flow to the bone, may reduce sufficient supply to that part, ultimately leads to necrosis. Head of femur is particularly susceptable to necrosis because of its supply of blood from end arteries. Avascular necrosis (AVN) of t hip joint can thus result from the reduced supply of blood, which ultimately give rise to local ischemia and further complication such as necrosis. Recent observations indicate a surge in AVN cases following COVID-19, likely due to virus-induced microvascular damage. Standard therapies fail to address the underlying vascular pathology.
Objective: To assess the clinical and radiological outcomes of a novel approach to treat Avascular hip necrosis patients with etiology of Covid 19.